An Open Invitation

On creating communal, equitable discourse to broaden participation in genetics research

Written byAaron Buseh
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

© BORTONIA/ISTOCKPHOTO.COMWhen geneticists take off their lab coats, leave the confines of their classrooms and workspaces, and venture into ethnic minority communities to share their work, they are fostering open discourse in a setting built on trust, understanding, autonomous decision-making, and participation. The creation of a “genetics table,” at which every party is welcome to discuss any and all emerging scientific and social issues related to genetics research, not only encourages inclusivity, but allows for frank, open discourse between ethnic minorities and researchers.

Controversial topics such as eugenics, cloning, scientific racism, and medical profiling are among those most likely to be broached by ethnic minorities. Long-held memories of the Tuskegee syphilis experiments and the more recent case of Henrietta Lacks’s cells being harvested without her consent—and subsequently used for profit—resonate within African American communities. (See “Debating Bioethics Openly,” The Scientist, July 2013.) With such an eye to the past, minority groups are apt to feel there are not enough ethical constraints in place to protect them from potential deception or abuse if they participate in genetics research.

The same ethical issues are also relevant to biobanking, which raises concerns over the possibility of for-profit products being derived from volunteers’ samples. And while ethnic minorities may rightfully wish to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies